secwatch.observer — SEC 8-K summary
======================================

Issuer:     Surrozen, Inc./DE (SRZN)
CIK:        0001824893
Form:       8-K
Filed at:   2025-03-28T23:59:59+00:00
Accession:  0000950170-25-046769
Event type: other_material
Sentiment:  neutral
Materiality: 0.80
Item codes: 1.01, 3.02, 5.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Surrozen raises ~$76.4M in first tranche private placement; appoints Tim Kutzkey to Board
--------------------------------------------------------------------------------

- First tranche closed March 26, 2025; gross proceeds ~$76.4M from 6,586,415 Units at $11.60 each.
- Each Unit includes one share (or pre-funded warrant) and one-half Series E Common Warrant ($11.54 exercise, 5-year term).
- Second tranche of up to 8,499,821 Units (~$98.6M) conditioned on FDA IND clearance for SZN-8141 by Oct 31, 2026.
- Series C and D warrants cancelled; Series A and B exercise prices reduced to $11.54 (management: $12.45).
- Dr. Tim Kutzkey (The Column Group) appointed as Class I director; initial option grant for 2,666 shares at $10.66.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1824893/000095017025046769/0000950170-25-046769-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1824893/000095017025046769/srzn-20250324.htm
  HTML page:      https://secwatch.observer/filing/0000950170-25-046769

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer